Evidence map›Paper›PMID 35620394›Full record

ArticleFrontiers in endocrinology2022

Troponin T Is Negatively Associated With 3 Tesla Magnetic Resonance Peripheral Nerve Perfusion in Type 2 Diabetes.

Johann M E Jende, Christoph Mooshage, Zoltan Kender, Lukas Schimpfle, Alexander Juerchott, Peter Nawroth, Sabine Heiland, Martin Bendszus, Stefan Kopf, Felix T Kurz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Johann M E JendeDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Christoph MooshageDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Zoltan KenderDepartment of Endocrinology, Diabetology and Clinical Chemistry (Internal Medicine 1) Heidelberg University Hospital, Heidelberg, Germany.
Lukas SchimpfleDepartment of Endocrinology, Diabetology and Clinical Chemistry (Internal Medicine 1) Heidelberg University Hospital, Heidelberg, Germany.
Alexander JuerchottDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Peter NawrothDepartment of Endocrinology, Diabetology and Clinical Chemistry (Internal Medicine 1) Heidelberg University Hospital, Heidelberg, Germany.
Sabine HeilandDivision of Experimental Radiology, Department of Neuroradiology, Heidelberg, Germany.
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Stefan KopfDepartment of Endocrinology, Diabetology and Clinical Chemistry (Internal Medicine 1) Heidelberg University Hospital, Heidelberg, Germany.
Felix T KurzDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
University Hospital Heidelberg · DEHeidelberg University · DEHeidelberger Institut für Radioonkologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The pathogenesis of diabetic polyneuropathy (DN) is poorly understood and given the increasing prevalence of DN, there is a need for clinical or imaging biomarkers that quantify structural and functional nerve damage. While clinical studies have found evidence of an association between elevated levels of troponin T (hsTNT) and N-terminal pro brain natriuretic peptide (proBNP) with microvascular compromise in type 2 diabetes (T2D), their implication in mirroring DN nerve perfusion changes remains unclear. The objective of this study was, therefore, to investigate whether hsTNT and proBNP assays are associated with MRI nerve perfusion in T2D. Methods: In this prospective cross-sectional single-center case-control study, 56 participants (44 with T2D, 12 healthy control subjects) consented to undergo magnetic resonance neurography (MRN) including dynamic contrast-enhanced (DCE) perfusion imaging of the right leg. Using the extended Tofts model, primary outcome parameters that were quantified are the sciatic nerve's microvascular permeability (K Results: In T2D patients, hsTNT was negatively correlated with K Conclusions: This study is the first to find that hsTNT is correlated with a decrease of microvascular permeability and a reduced extravascular extracellular volume fraction of nerves in patients with T2D. The results indicate that hsTNT may serve as a potential marker for the assessment of nerve perfusion in future studies on DN.

Indexed as

Diabetes Mellitus, Type 2Troponin TBiomarkersCase-Control StudiesCross-Sectional StudiesHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyPerfusionPeripheral NervesProspective StudiesBiomarkersTroponin Tdiabetic neuropathydynamic contrast enhancementmagnetic resonance neurographyperfusiontroponin T

Identifiers

PMID35620394
PMCPMC9127234
OpenAlexW4229450650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.